CENTERVUE S.p.A. was established in 2008 in Padova. The US subsidiary was opened in 2012.
Today, CENTERVUE is part of Revenio Group. Revenio is one of the leading players in eye diagnostics solutions and ophthalmic products worldwide providing state-of-the-art technology to enable efficient diagnostics of eye diseases. Revenio’s eye related products include CENTERVUE imaging products for the diagnostics and monitoring of the eye as well as Icare tonometers for intraocular pressure measurement (IOP).
Revenio focuses on high-technological diagnostic systems for the early detection and management of sight-threatening pathologies such as Glaucoma, Diabetic Retinopathy and Macular Degeneration.